Description

BPC-157 Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids. It was originally derived from a naturally occurring protein fragment identified in gastric tissue. Since its discovery in the early 1990s, BPC-157 has been studied extensively in laboratory and animal models for its potential influence on cellular protection, structural repair, and angiogenic processes.

Sikiric P. et al. (1993).

History

The peptide was first synthesized by researchers investigating cytoprotective proteins found in gastric juice. Early experiments focused on its ability to support structural integrity in gastrointestinal models. Over time, studies broadened into musculoskeletal, vascular, and dermal systems, where BPC-157 consistently demonstrated properties of interest in the context of tissue regeneration and biological resilience.

Pflaum, M., & Ručman, R. (2005).

BPC-157 Structure

CAS #: 137525-51-0

Molecular Formula: C₆₂H₉₈N₁₆O₂₂

Molecular Weight: 1419.556 g/mol

PubChem ID: 108101

Research Findings

BPC-157 has been studied in structural, vascular, dermatological, and systemic models, with reports of activity in collagen regulation, extracellular matrix remodeling, angiogenesis, and wound closure. Research also highlights protective roles in preclinical systems, supporting cellular integrity and recovery processes.

Key Areas of Research:

• Structural: Collagen, matrix, tendon
  
    • Vascular: Angiogenesis, nitric oxide, repair
  
      • Dermatological: Wound closure, vessel growth, cells
• Systemic: Protection, viability, recovery

Together, these findings suggest broad experimental utility for BPC-157 across multiple biological pathways. Its activity in structural, vascular, dermatological, and systemic models provides a foundation for exploring diverse aspects of regenerative biology. By influencing processes such as collagen regulation, vascular growth, and cellular protection, BPC-157 offers a versatile platform for research into tissue repair, recovery, and systemic resilience within experimental settings.

Sikiric P. et al., Current Pharmaceutical Design, 2020

References

Sikiric P. et al. (1993). A new gastric juice peptide, including BPC-157, characterized and synthesized.

Pavlovic I. et al. (2003). The promoting effect of pentadecapeptide BPC-157 on tendon healing involves tendon outgrowth, cell survival and cell migration.

Staresinic M. et al. (2003). Effects of BPC-157 on ligament and tendon repair in experimental models.

Chang CH. et al. (2009). Protective effects of BPC-157 in experimental colitis models.

Hsieh MJ. et al. (2015). Therapeutic potential of pro-angiogenic BPC-157 in wound healing and burn models.

Seiwerth S. et al. (2018). Mechanisms of angiogenic activity and NO-system modulation by BPC-157

Kang EA. et al. (2025). Protective effects of BPC-157 on liver, kidney, and lung in ischemia–reperfusion injury models.